Recombinant Human PARP9 Protein，His

PARP9 (poly(ADP-ribose) polymerase 9) is a member of the PARP family, which is involved in various cellular processes, including DNA repair, apoptosis, and regulation of gene expression. Initially identified as a protein with mono(ADP-ribosyl) transferase activity, PARP9 has gained attention for its role in immune responses, particularly in the regulation of the primary immune effector molecules and the modulation of inflammatory pathways. Research has highlighted that PARP9 interacts with other proteins, such as histone and non-histone substrates, thereby influencing chromatin dynamics and cellular signaling. This makes PARP9 a potential target for therapeutic interventions in various diseases, including cancer and inflammatory disorders. The study of recombinant PARP9 protein is crucial for understanding its biochemical properties and mechanistic functions in cellular contexts. By producing PARP9 in a recombinant system, researchers can investigate its enzymatic activities, binding affinities, and interactions with other cellular components. This knowledge may provide insights into the development of PARP inhibitors that could enhance the efficacy of cancer treatments, particularly in tumors that exhibit resistance to conventional therapies. Furthermore, the characterization of PARP9 could unveil novel regulatory pathways and contribute to the design of targeted therapies aimed at modulating immune responses in diseases involving chronic inflammation or autoimmunity. Overall, the exploration of PARP9, particularly in its recombinant form, promises to deepen our understanding of its biological significance and potential as a therapeutic target.